Mental Health Clinics in Clarksville, TN Accepting Medicare
105 Mental Health Clinics found. Showing 101 - 105
 Serenity Within Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 1038 Black Gum Ln, Clarksville, TN 37043 Phone: 615-979-0789 |
Center For Neurological Treatment & Research, Pllc Psychiatry & Neurology - Neurology Medicare: Not Enrolled in Medicare Practice Location: 331 Landrum Pl, Clarksville, TN 37043 Phone: 615-355-5510 Fax: 615-355-8699 |
Imani Behavioral Health, Pllc Psychologist Medicare: Medicare Enrolled Practice Location: 93 Beaumont St, Clarksville, TN 37040 Phone: 931-919-2686 |
People First Therapeutic Solutions S.c. Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 2116 Richview Pl, Clarksville, TN 37043 Phone: 931-278-5326 |
Pillars Of Hope Counseling Llc Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 128 Trillium Ct, Clarksville, TN 37043 Phone: 573-673-8434 |
News Archive
Can-Fite's CF102 drug gets approval in Israel for patient with hepatocellular carcinoma
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that the Israeli Ministry of Health has approved the use of its drug CF102 for a patient with hepatocellular carcinoma, the most common form of liver cancer, under the country's Compassionate Use Program.
PCMA releases statement on President Obama's budget proposal for biotech medications
Pharmaceutical Care Management Association President and CEO Mark Merritt released the following statement on President Obama's budget proposal that would grant brand-name drug manufacturers seven years of market exclusivity before generic versions of biologic products can enter the market, instead of the 12 years that was passed in the health reform bill.
BIOTRONIK's EchoCRT clinical trial design published in European Heart Journal
BIOTRONIK SE & Co. KG, a leading manufacturer of implantable cardiac devices and sponsor of clinical research to advance patient care and evidence-based medicine, announced the publication in the September 23, 2010 issue of the European Heart Journal of a peer-reviewed article that describes the rationale for the echocardiographic methods and dyssynchrony cutoff values selected for the EchoCRT study.
Inflammasome may lead to more damage following heart attack
Virginia Commonwealth University researchers have found that an inflammatory mechanism known as inflammasome may lead to more damage in the heart following injury such as a heart attack, pointing researchers toward developing more targeted strategies to block the inflammatory mechanisms involved.
Testosterone therapy for prostate cancer needs reevaluation: New study
The long-standing prohibition against testosterone therapy in men with untreated or low-risk prostate cancer merits reevaluation, according to a new study published in The Journal of Urology.
› Verified 6 days ago